Why normal blood tests can coexist with pattern hair loss, why baldness does not measure testosterone, and what to ask when someone promises to balance your hormones.
![[headshot]](https://cdn.prod.website-files.com/68207da82e5b8c350c67932f/68c6a7436a552c0fe87a4da7_Screenshot%202024-11-27%20at%2011.38.11.png)
There is a familiar claim that men go bald because they have more testosterone. It turns an unwelcome change into a flattering explanation, but it is not a useful account of the biology.
DHT contributes to male pattern hair loss by acting on susceptible follicles. Many men with hair loss have normal testosterone levels, and men with similar blood results can have very different hairlines. Genetics, local hormone metabolism and the follicle’s response all matter.
You cannot infer someone’s libido, fertility or testosterone level from how much hair they have. Nor does deliberately pushing testosterone below a healthy range offer a sensible general hair-loss strategy.
A blood test can help identify an endocrine disorder. It does not measure every signal inside a scalp follicle or tell you whether individual hairs are miniaturising.
This distinction matters when someone has been told that all their results are normal and therefore nothing is wrong. Normal results may rule out particular contributors while leaving a clear clinical diagnosis of pattern hair loss.
The opposite mistake is to assume that any mildly abnormal result must explain the hair. A result needs interpreting alongside symptoms, the scalp examination and the timing of the change.
Some women with thinning have androgen excess, but many do not. Female pattern hair loss is not uniformly androgen-dependent, so it should not be described as exactly the same hormonal process as male pattern loss.
Irregular periods, new facial hair or persistent acne can justify investigating androgen excess and conditions such as polyendocrine metabolic ovarian syndrome (PMOS), previously called PCOS. A widening parting alone does not establish that diagnosis.
Normal androgen results do not automatically exclude a possible role for an anti-androgen medicine. They also do not prove that such a medicine will help. That decision depends on the clinical picture and the evidence for the proposed treatment.
Starting or stopping a hormonal medicine can be followed by shedding in some people. Pregnancy and childbirth can also change the hair cycle. The sequence is worth discussing, but a change after an event does not prove that the event explains every subsequent hair problem.
For example, a postpartum shed may reveal underlying pattern loss. A woman near menopause may have more than one contributor to thinning. The explanation should remain open to those overlaps.
Do not stop prescribed contraception, hormone replacement or gender-affirming treatment without discussing the concern with the prescriber. Hair can be considered alongside the treatment’s other benefits and risks.
Menopausal hormone therapy is prescribed for appropriate menopausal indications after an individual assessment. It is not a reliable standalone treatment for female pattern hair loss, and “oestrogen helps hair” is too broad a claim to justify starting it.
Thyroid disease can cause shedding, and treating it is important. Hair recovery may take longer than normalisation of the blood results. If thinning persists, another cause may also be present.
A borderline thyroid test should be interpreted according to clinical guidance and the person’s circumstances. Treating an isolated number solely to chase hair growth can add risk without establishing that the thyroid caused the loss.
When a product or service uses that phrase, ask which hormone is abnormal, how that was established, and what evidence shows that the proposed treatment improves this type of hair loss.
A laboratory mechanism is a starting point for research, not proof of a useful result in people. “Natural” does not mean hormonally inactive or free from adverse effects. A supplement that claims to block DHT should still be asked to show meaningful human benefit and adequate safety information.
The same scrutiny belongs here too. I want the explanations on Hairline Helpline to make the limits of the evidence visible, so you can decide what deserves attention and what is just a persuasive-sounding story.
